223|645|Public
50|$|Intracellular {{signaling}} by chemokine receptors {{is dependent}} on neighbouring G-proteins. G-proteins exist as a heterotrimer; they are composed of three distinct subunits. When the molecule GDP is bound to the G-protein subunit, the G-protein is in an inactive state. Following binding of the chemokine ligand, chemokine receptors associate with G-proteins, allowing the exchange of GDP for another molecule called GTP, and the dissociation of the different G protein subunits. The subunit called Gβ activates an enzyme known as Phospholipase C (PLC) {{that is associated with}} the cell membrane. PLC cleaves Phosphatidylinositol (4,5)-bisphosphate (PIP2) to form two second messenger molecules called inositol triphosphate (IP3) and diacylglycerol (DAG); DAG activates another enzyme called protein kinase C (PKC), and IP3 triggers the release of calcium from intracellular stores. These events promote many signaling cascades, effecting a cellular response. For example, when CXCL8 (IL-8) binds to its specific receptors, CXCR1 or CXCR2, a rise in intracellular calcium activates the enzyme phospholipase D (PLD) that goes on to initiate an intracellular signaling cascade called the MAP kinase pathway. At the same time the G-protein subunit Gα directly activates an enzyme called protein tyrosine kinase (PTK), which phosphorylates serine and threonine residues in the tail of the chemokine receptor, causing its desensitisation or inactivation. The initiated MAP kinase pathway activates specific cellular mechanisms involved in chemotaxis, degranulation, release of superoxide anions, and changes in the avidity of cell adhesion molecules called integrins. Chemokines and their receptors {{play a crucial role in}} cancer metastatis as they are involved in extravastation, migration, micrometastatis, and angiogenesis. This role of chemokine is strikingly similar to their normal function of localizing leukocytes to an <b>inflammatory</b> <b>site.</b>|$|E
50|$|Through most of {{its early}} period of study, acute {{inflammatory}} responses were regarded as self-limiting innate immune system reactions to invading foreign organisms, tissue injuries, and other insults. These reactions were orchestrated by various soluble signaling agents such as a) foreign organism-derived N-formylated oligopeptide chemotactic factors like N-Formylmethionine-leucyl-phenylalanine; b) Complement component 5a and C3a (complement) chemotactic factors formed during the activation of the host's blood complement system by the invading organisms or injured tissues; and c) host cell-derived cytokines, chemokines, platelet-activating factor, and numerous PUFA metabolites including prostaglandins, leukotrienes such as leukotriene B4, Hydroxyeicosatetraenoic acids such as 5-HETE, and oxoeicosanoids such as 5-oxo-eicosatetraenoic acid. These agents act as cell signaling agents to increase the permeability of local blood vessels; activate nearby tissue-bound endothelial cells, mast cells, and macrophages; and attract to the nascent <b>inflammatory</b> <b>site</b> and further activated circulating neutrophils, monocytes, eosinophils, Gamma delta T cells, and Natural killer T cells. These reactions trended to neutralize invading organisms, limit tissue injury, and initiate tissue repair; they were viewed as resolving automatically consequential to the dissipation of signaling agents and thereby the recruitment and activation of pro-inflammatory cells. In 1974, however, Charles N. Serhan and his renowned colleagues, Mats Hamberg and Bengt Samuelsson, discovered that human neutrophils metabolized arachidonic acid to two novel products that contained 3 hydroxyl residues and 4 double bonds viz., 5,6,15-trihydroxy-7,9,11,13-icosatetraenoic acid and 5,14,15-trihydroxy-6,8,10,12-icosatetraenoic acid. These products are now termed lipoxin (Lx)A4 and LxB4, respectively. While initially found to have in vitro activity suggesting that they might act as pro-inflammatory agents, Serhan and colleagues as well as numerous other groups found that these lipoxins {{as well as many}} other newly discovered metabolites of various PUFA possess primarily if not exclusively anti-inflammatory activities in vivo as well as in vitro. These many products were termed specialized pro-resolving mediators or SPM.|$|E
40|$|During {{the course}} of {{inflammation}} and its resolution, macrophages are exposed to various cytotoxic materials, including reactive oxygen species. Thus, macrophages require a protective machinery against oxidative stress to survive at the <b>inflammatory</b> <b>site.</b> Here, we showed that xCT, a component of transport system xc−, was significantly up-regulated in activated infiltrating cells, including macrophages and neutrophils at the <b>inflammatory</b> <b>site.</b> System xc− mediates the uptake of extracellular L-cystine and is consequently responsible for maintenance of intracellular glutathione levels. We established a loss-of-function mouse mutant line of xCT by N-ethyl-N-nitrosourea mutagenesis. Macrophages from xCTmu/mu mice showed cell death {{in association with the}} excessive release of high mobility group box chromosomal protein 1 upon stimulation with LPS, suggesting that xCT deficiency causes unremitting inflammation because of the impaired survival of activated macrophages at the <b>inflammatory</b> <b>site.</b> Subcutaneous injection of 3 -methylcholanthrene (3 -MCA) induced the generation of fibrosarcoma in association with inflammation. When 3 -MCA was injected s. c. into mice, xCT mRNA was up-regulated in situ. In xCTmu/mu mice, inflammatory cytokines (such as IL- 1 β and TNFα) were overexpressed, and the generation of 3 -MCA-induced fibrosarcoma was accelerated. These results clearly indicate that the defect of the protective system against oxidative stress impaired survival of activated macrophages and subsequently enhanced tumorigenecity...|$|E
50|$|E-selectin recognizes and binds to sialylated {{carbohydrates}} {{present on}} the surface proteins of certain leukocytes. E-selectin ligands are expressed by neutrophils, monocytes, eosinophils, memory-effector T-like lymphocytes, and natural killer cells. Each of these cell types is found in acute and chronic <b>inflammatory</b> <b>sites</b> in association with expression of E-selectin, thus implicating E-selectin in the recruitment of these cells to such <b>inflammatory</b> <b>sites.</b>|$|R
50|$|The Department of Vascular Cell Biology is concentrating its {{research}} on leukocyte migration into <b>inflammatory</b> <b>sites.</b>|$|R
40|$|BEH ÇET’S disease (BD) is {{a current}} {{systemic}} vasculitis of unknown aetiology. Eyes, skin, joints, the oral cavity, genital system, blood vessels, {{central nervous system}} and lung are usually involved. Defective regulation of programmed cell death (apoptosis) {{may play a role}} in the development of (BD), and the protooncogene Bcl- 2 is involved in the control of apoptosis in immunocompetent cells. We therefore wished to investigate the expression of Bcl- 2 in the peripheral lymphocytes and in two <b>inflammatory</b> <b>sites</b> of patients with active BD: bronchoalveolar lavage (BAL) and cerebrospinal fluid (CSF) lymphocytes. Levels of Bcl- 2 expression in the lymphocytes of patients with BD and, for comparison, in the lymphocytes of healthy controls and non-inflammatory neurological diseases (NIND), were studied by two-colour cytofluorography and RNA analysis. In BD patients, a significant proportion of T cells expressed increased amounts of Bcl- 2 protein, both in peripheral blood and in <b>inflammatory</b> <b>sites.</b> Mononuclear cells of patients with BD showed increased amount of Bcl- 2 messenger RNA. The in vitro incubation of T lymphocytes with IL- 10, significantly increased the Bcl- 2 expression, specifically in T lymphocytes from <b>inflammatory</b> <b>sites.</b> In active BD, stimulation of HSV- 1 T lymphocytes slightly increased Bcl- 2 expression, not significantly different from unstimulated HSV- 1 T cells. The occurrence of circulating T lymphocytes with abnormally high Bcl- 2 expression in peripheral circulation and in <b>inflammatory</b> <b>sites</b> may be explained in part by the increased in vivo activation levels, and by aetiopathological agent(s) : our findings seem to indicate an important role in the chronic inflammation in BD. Expression of Bcl- 2 in <b>inflammatory</b> <b>sites</b> from patients with active Behçet’s diseas...|$|R
40|$|Inflammation is {{associated}} with immune cells infiltrating into the <b>inflammatory</b> <b>site</b> and pain. CC chemokine receptor 1 (CCR 1) mediates trafficking of leukocytes to sites of inflammation. However, the contribution of CCR 1 to pain is incompletely understood. Here we report an unexpected discovery that CCR 1 -mediated trafficking of neutrophils and CCR 1 activity on non-hematopoietic cells both modulate pain. Using a genetic approach (CCR 1 -/- animals) and pharmacological inhibition of CCR 1 with selective inhibitors, we show significant reductions in pain responses using the acetic acid-induced writhing and complete Freund's adjuvant-induced mechanical hyperalgesia models. Reductions in writhing correlated with reduced trafficking of myeloid cells into the peritoneal cavity. We show that CCR 1 is highly expressed on circulating neutrophils and their depletion decreases acetic acid-induced writhing. However, administration of neutrophils into the peritoneal cavity did not enhance acetic acid-induced writhing in wild-type (WT) or CCR 1 -/- mice. Additionally, selective knockout of CCR 1 in either the hematopoietic or non-hematopoietic compartments also reduced writhing. Together {{these data suggest that}} CCR 1 functions to significantly modulate pain by controlling neutrophil trafficking to the <b>inflammatory</b> <b>site</b> and having an unexpected role on non-hematopoietic cells. As inflammatory diseases are often accompanied with infiltrating immune cells at the <b>inflammatory</b> <b>site</b> and pain, CCR 1 antagonism may provide a dual benefit by restricting leukocyte trafficking and reducing pain...|$|E
40|$|A rabbit {{model was}} used to {{study the effects of}} {{neutropenia}} and inflammation on the intravascular distribution, survival, and tissue accumulation of transfused neutrophils. Donor blood labeled with [3 H]thymidine was infused into normal or neutropenic (vinblastine treated) animals. Inflammation was created by subcutaneous implantation of polyvinyl sponges, some with added endotoxin. Initial circulating neutrophil pool recovery, survival, and <b>inflammatory</b> <b>site</b> accumulation of labeled neutrophils were measured...|$|E
40|$|Rationale: Neutrophils {{are usually}} the first {{circulating}} leukocytes to respond during bacterial pneumonia. Their expression of oxidants, proteases, and other mediators present in granules is well documented, but their ability to produce mediators through transcription and translation after migration to an <b>inflammatory</b> <b>site</b> has been appreciated only more recently. Interferon (IFN) -γ is a cytokine with many functions important in host defense and immunity...|$|E
40|$|Homing of 51 Cr-labelled spleen and lymph node-derived T- and B-cell subpopulations into <b>inflammatory</b> <b>sites</b> in the skin, {{as well as}} into lymphoid and non-lymphoid organs, was {{studied in}} outbred and inbred guinea-pigs. The early progeny of {{activated}} T cells were demonstrated in immunologically-mediated inflammation of the skin, for example a cell-mediated immune reaction and a reversed passive Arthus reaction. In contrast, spleen and lymph node-derived B cells were virtually unable to enter <b>inflammatory</b> <b>sites.</b> Organ-specific homing of T and B cells was detected. The significance of these observations for the interpretation of results of lymphoid cell transfers in guinea-pigs is discussed...|$|R
40|$|Hypothalamic corticotropin-releasing hormone (CRH) acts as {{the major}} {{physiologic}} ACTH secretagog. Moreover, CRH is distributed {{in the brain and}} spinal cord, adrenal medulla, testes, ovaries, gastrointestinal tract, pancreas, myometrium, endometrium, placenta, and diverse <b>inflammatory</b> <b>sites.</b> Immunoreactive CRH has been found in the cytoplasm of immune accessory cells (macrophages, endothelial cells, and tissue fibroblasts), and in <b>inflammatory</b> <b>sites</b> of both acute and chronic inflammation (synovial lining cell layers and blood vessels from the joints of patients with rheumatoid arthritis and osteoarthritis). Additionally, the local presence of CRH in the uveitic eyes, cytoplasm of inflammatory cells (macrophages, lymphocytes, and polymorphonuclear cells) infiltrating the iris, ciliary body, vitreous, retina, and choroid appears to be of pivotal importance in the process of experimental autoimmune uveoretinitis. Traditionally, hypothalamic CRH has been considered to act indirectly in an anti-inflammatory fashion, since the end product of the hypothalamic–pituitary– adrenal axis is cortisol, a well-known anti-inflammatory compound. However, CRH produced at peripheral <b>inflammatory</b> <b>sites</b> has been shown to participate in an autocrine/paracrine stimulation of inflammation. Thus, CRH may have a peripheral, primarily activating role on the immune system. Th...|$|R
40|$|Behçet's disease (BD) is {{a current}} {{systemic}} vasculitis of unknown aetiology. Eyes, skin, joints, the oral cavity, genital system, blood vessels, {{central nervous system}} and lung are usually involved. Defective regulation of programmed cell death (apoptosis) {{may play a role}} in the development of (BD), and the protooncogene Bcl- 2 is involved in the control of apoptosis in immunocompetent cells. We therefore wished to investigate the expression of Bcl- 2 in the peripheral lymphocytes and in two <b>inflammatory</b> <b>sites</b> of patients with active BD: bronchoalveolar lavage (BAL) and cerebrospinal fluid (CSF) lymphocytes. Levels of Bcl- 2 expression in the lymphocytes of patients with BD and, for comparison, in the lymphocytes of healthy controls and non-inflammatory neurological diseases (NIND), were studied by two-colour cytofluorography and RNA analysis. In BD patients, a significant proportion of T cells expressed increased amounts of Bcl- 2 protein, both in peripheral blood and in <b>inflammatory</b> <b>sites.</b> Mononuclear cells of patients with BD showed increased amount of Bcl- 2 messenger RNA. The in vitro incubation of T lymphocytes with IL- 10, significantly increased the Bcl- 2 expression, specifically in T lymphocytes from <b>inflammatory</b> <b>sites.</b> In active BD, stimulation of HSV- 1 T lymphocytes slightly increased Bcl- 2 expression, not significantly different from unstimulated HSV- 1 T cells. The occurrence of circulating T lymphocytes with abnormally high Bcl- 2 expression in peripheral circulation and in <b>inflammatory</b> <b>sites</b> may be explained in part by the increased in vivo activation levels, and by aetiopathological agent(s) : our findings seem to indicate an important role in the chronic inflammation in BD...|$|R
40|$|A {{method is}} {{presented}} for the immunohistochemical localization of Cx-reactive protein in rabbits, {{based on the}} use of a defined antiserum and rigorous fixation techniques requisite for this antigen. In animals in which inflammatory lesions and CxRP response were induced by intramuscular injection of typhoid vaccine, Cx-reactive protein was localized only in the area of local inflammation within muscle fibers showing morphologic evidence of necrotic change. Within such altered fibers, CxRP was observed in peripheral segments of myofiber or in subsarcolemmal sarcoplasm, in scattered deposits in sarcoplasm, and in vacuolar inclusions. No CxRP was found at any time in polymorphonuclear or mononuclear cells in the inflammatory lesion, nor in contralateral muscle, regional or distal lymph nodes, liver, spleen, thymus, heart, or kidney, except as traces in lumens of vessels or interstitium. CxRP was first detected in necrotic myofibers at the <b>inflammatory</b> <b>site</b> after a latent period of 8 to 10 hours following injection of the inflammatory stimulus and could be demonstrated in these sites for the 48 hours of the experiment. It could not be observed at the <b>inflammatory</b> <b>site</b> before appearance in the blood. Identical histologic localization in necrotic myofibers {{at the site of the}} local lesions was found following induction of granulocytopenia with nitrogen mustard. These findings are consistent with the hypothesis that CxRP is formed locally at the site of inflammation from tissue elements undergoing necrotic change. Alternatively, secondary deposition from the blood at the <b>inflammatory</b> <b>site</b> cannot be excluded, but is considered less likely in view of the failure to obtain evidence of a cellular localization of CxRP in other organs...|$|E
40|$|Delayed-type {{hypersensitivity}} {{has been}} differentiated from {{other types of}} hypersensitivity reactions by its delayed onset {{and the nature of}} the cellular infiltrate. In a study of the histology of anaphylactic reactions in the skin, Dienes and Mallory (1932) noted that there was a polymorphonuclear infiltration in the early stages of an anaphylactic reaction, whereas the tuberculin reaction was characterized from the onset by a predominance of mononuclear cells. Follis (1940) duplicated the techniques of Dienes and Mallory, but could find no evidence of an early infiltration by mononudcar cells. He found that the proportion of mononudcar cells increased over 20 hr of observation; most of the accumulation occurred during the first 12 - 16 hr. At best the mononuclear cells accounted for 43 % of the total migratory cells in a tuberculin reaction compared to 58 % in a nonspecific <b>inflammatory</b> <b>site.</b> On the whole, the increased numbers of mononuclear cells in the tuberculin site and the <b>inflammatory</b> <b>site</b> were comparable. There are thus two views on the cellular events culminating in the lesion associate...|$|E
40|$|Objectives The {{aim was to}} {{test the}} {{potential}} use of an extract of Mikania laevigata (popularly known in Brazil as guaco), made from leaves harvested in different months of the year, oil neutrophil migration after all inflammatory Stimulus and investigate the underlying molecular mechanisms. Methods We examined the effect of guaco on vascular permeability and leucocyte function in carrageenan-induced peritonitis in mice. Key findings Our results demonstrated that guaco extract administered subcutaneously (3 mg/kg) decreased the vascular permeability and also leucocyte rolling and adhesion to the inflamed tissues by a mechanism dependent on nitric oxide. Specifically, inhibitors of nitric oxide synthase remarkably abrogated the guaco extract-mediated suppression of neutrophil migration to the <b>inflammatory</b> <b>site.</b> In addition, guaco extract-mediated suppression of neutrophil migration appeared {{to be dependent on}} the production of the cytokines interleukin- 1 beta and tumour necrosis factor-alpha. One of the major constituents of the guaco extract, coumarin, was able to inhibit the neutrophil migration towards the inflammatory focus. Conclusions In conclusion the anti-inflammatory effect induced by guaco extract may be by inhibition of pro-inflammatory cytokine production at the <b>inflammatory</b> <b>site.</b> PAPE-UNIUBE[2007 / 002]CAPESFundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [34 / 07...|$|E
40|$|Dendritic cells (DCs) {{play key}} roles in immune {{regulation}} as professional antigen-presenting cells. There are three stages of differentiation: DCs precursors, immature DCs (iDCs), and mature DCs (mDCs). 1 — 3) iDCs locate in various tissues and migrate to <b>inflammatory</b> <b>sites.</b> iDCs capture anti-gens such as invading bacteria and viruses at <b>inflammatory</b> <b>sites</b> and then process the antigens for presentation on {{major histocompatibility complex}} molecules. Pathogen-derived components or pro-inflammatory cytokines can induce the maturation of DCs. During maturation, the DCs express chemokine receptor CCR 7 and migrate from the inflamma-tion site to the lymphoid organs in response to chemokines such as CCL 19 (macrophage inflammatory protein- 3 b; MIP- 3 b) and CCL 21. 4) mDCs acquire a high antigen-presenting capacity and thereby vigorously stimulate the T-cell re...|$|R
30|$|In addition, we {{performed}} flow cytometry-based staining of various gut homing molecules on monocytes and found, {{in agreement with}} our studies on human GM-CSF-activated monocytes, CCR 2, necessary for migration toward <b>inflammatory</b> <b>sites,</b> and CCR 6, used for the migration toward lymph follicles such as Peyer patches, to be upregulated on murine GM-CSF-activated monocytes [16].|$|R
40|$|AbstractInteractions between {{immunoglobulin}} superfamily (IgSF) {{members and}} integrins {{are central to}} lymphocyte homing, leukocyte emigration into tissues at <b>inflammatory</b> <b>sites,</b> and in cell-cell interactions that lead to immune responses. Recent X-ray crystal structures reveal that the interaction of a divalent cation found in the integrin structure with an acidic residue from the IgSF partner may be important in binding...|$|R
40|$|In {{response}} to injury, monocytes {{migrate to the}} site of inflammation, where they differentiate into macrophages and participate in various biologic processes. However, their fate during the resolution of acute inflammation is not fully understood. Here, we show that inflammatory macrophages do not die locally by apoptosis; rather, they migrate across the peritoneal mesothelium to the lymphatics, through which they further migrate to the lymph nodes and to the blood circulation. Macrophage efflux is enhanced considerably on cell activation, and such accelerated macrophage migration is dependent specifically on integrin Mac- 1, and can be blocked by addition of its antagonist. Thus, genetic inactivation of Mac- 1 in mice inhibits the accelerated macrophage efflux from the <b>inflammatory</b> <b>site</b> to the lymphatics, but it does not compromise the accumulation of blood monocytes into the <b>inflammatory</b> <b>site.</b> Together, our study demonstrates that Mac- 1 is involved specifically in the efflux of activated macrophages to the lymphatics, suggesting that Mac- 1 may {{play an important role in}} the removal of local inflammatory macrophages and in their subsequent migration to the lymph nodes, a process that is critical to the development of the adaptive immunity...|$|E
40|$|Sphingolipids are {{constituents}} of cellular membranes and play important roles as second messengers mediating cell functions. As significant components in foods, sphingolipids {{have been proven}} to be critical for human health. Moreover, diverse metabolic intermediates of sphingolipids are known to play key roles both in proinflammatory and in anti-inflammatory effects. However, the effect of dietary sphingolipids on inflammation is a complicated field {{that needs to be}} further assessed. Our study evaluated the effects of orally administered maize glucosylceramide (GluCer), one of the most conventional dietary sphingolipids, on inflammation using the 2, 4 -dinitro- 1 -fluorobenzene-treated BALB/c murine model. Oral administration of GluCer inhibited ear swelling and leukocyte infiltration to the <b>inflammatory</b> <b>site,</b> suggesting that dietary GluCer has anti-inflammatory properties. ELISA analyses revealed that oral administration of GluCer for 6  days had not modified the Th 1 /Th 2 balance, but significantly down-regulated the activation of TNF-α at the <b>inflammatory</b> <b>site.</b> Based on these results, the down-regulation of TNF-α by dietary GluCer may suppress vascular permeability and reduce the migration of inflammatory cells. Our findings increase understanding of the actions of dietary sphingolipids on the balance of the immune response...|$|E
40|$|The {{relationship}} between oxygen-radical production by rat polymorphonuclear leucocytes and O 2 concentration {{was established by}} the measurement of luminol-dependent chemiluminescence at defined O 2 concentrations. The O 2 concentration that gave 50 % of the maximum stimulated oxygen-radical production was 31 +/- 9 microM for non-opsonized latex beads and 22 +/- 9 microM for chemotactic peptide. The O 2 concentration in rheumatoid synovial fluid was approx. 30 microM. It is therefore proposed that radical production at an <b>inflammatory</b> <b>site</b> may be limited by O 2 concentratio...|$|E
40|$|T cells infiltrating <b>inflammatory</b> <b>sites</b> {{are usually}} of the acti-vated/memory type. The precise {{mechanism}} for the posi-tioning of these cells within tissues is unclear. Adhesion mole-cules certainly play a role; however, the intricate control of cell migration appears to be mediated by numerous chemo-kines and their receptors. Particularly important chemo-kines for activated/memory T cells are the CXCR 3 ligand...|$|R
40|$|A {{critical}} role for leukotriene B 4 (LTB 4) and/or platelet-activating factor (PAF) in regulating polymorphonuclear cell (PMN) trafficking to <b>inflammatory</b> <b>sites</b> {{has been reported}} in a number of experimental inflammatory models. In vitro, newly synthesized LTB 4 and PAF were shown to act in an autocrine/paracrine or intracrine fashion to enhance intracellular arachidonic acid availability and leukotriene biosynthesis. This suggested potentially cooperative effects of these lipid mediators in regulating PMN extravasation. The present study aimed to elucidate whether endogenous LTB 4 and PAF may both act to regulate plasma extravasation and PMN trafficking to <b>inflammatory</b> <b>sites</b> in experimental inflammation. With this aim, we have used selective and potent PAF and LTB 4 receptor antagonist pretreatments in dermal and pulmonary inflammation models in rats. Our results show additive inhibitory effects of dual LTB 4 and PAF receptor blockade in either PAF- or LTB 4 -elicited cutaneous PMN accumulation compared to single-drug administration. Furthermore, the combined administration of the drugs inhibited the PMN accumulation induced by the chemically unrelated soluble agonists tumour necrosis factor-α and C 5 a. Finally, in a model of pulmonary inflammation induced by the intravenous injection of Sephadex beads, lung neutrophilia was reduced by 63 % following the administration of LTB 4 and PAF antagonists, in contrast with the lack of effect of single drug administration. Our results strongly support a role of both endogenous LTB 4 and PAF in regulating PMN trafficking to <b>inflammatory</b> <b>sites</b> in various experimental conditions...|$|R
40|$|Adhesion of {{lymphocytes}} to endothelium {{is vital}} to lymphocyte migration into lymphoid tissue and into <b>inflammatory</b> <b>sites.</b> In this review, Yoji Shimizu and colleagues identify the molecules that mediate lymphocyte-endothelial cell adhesion, describe the underlying principles of lymphocyte migration, and discuss {{a model of the}} sequence of events that allow a lymphocyte to successfully attach to endothelium and migrate into the surrounding tissue...|$|R
40|$|The {{influence}} of endogenous nitric oxide (NO) on prostaglandin biosynthesis in rat carrageenin oedema was studied. Oedema formation and prostaglandin E 2 generation in the inflamed paw were both increased by L- but not D-arginine and {{reduced by the}} NO synthase inhibitor, L-NG-nitro arginine methyl ester, and the NO scavenger, haemoglobin. Methylene blue, an inhibitor of the soluble guanylate cyclase, had no effect. These results suggest that endogenous NO modulates carrageenin oedema by increasing prostaglandin biosynthesis at the <b>inflammatory</b> <b>site</b> through a cGMP-independent mechanism...|$|E
30|$|According {{to these}} results, sesame oil {{decreased}} the MSU crystal-induced activation of nuclear NF-κB in mast cell, and mast cell stabilizer ketotifen blockaded inflammatory cells infiltration in MSU crystal-treated rats. We suggest that inhibiting mast cell degranulation accounts for sesame oil’s anti-inflammatory effect in MSU crystal-induced gouty inflammation. Further, {{in the present}} study, sesame oil inhibited IL- 4 release, mast cell degranulation and accumulation in <b>inflammatory</b> <b>site.</b> Therefore, we suggest that inhibiting IL- 4 production in mast cell is involved in sesame oil-associated anti-inflammatory effect against MSU crystal challenge.|$|E
40|$|Small vessel {{vasculitis}} {{is associated}} with harmful anti-neutrophil cytoplasmic antibodies directed against sheltered antigens Wegener’s granulomatosis and microscopic poly-angiitis are small vessel systemic vasculitides charac-terized {{by the presence of}} anti-neutrophil cytoplasmic antibodies (ANCA) and a high frequency of rapidly progressive glomerulonephritis. The main target anti-gens for ANCA are proteinase 3 (PR 3) and myelo-peroxidase (MPO). Both antigens are tightly sheltered from the immune system (cryptic). Indeed, they are stored in cytoplasmic granules of neutrophils, and are very rapidly scavenged after degranulation at the <b>inflammatory</b> <b>site</b> by specific inhibitors: a 1 -antitrypsin for PR 3 [1] and ceruloplasmin for MPO [2]. However...|$|E
40|$|Objectives To {{determine}} {{the effect of}} the eosinophil cationic granule proteins Major Basic Protein (MBP) and Eosinophil Peroxidase (EPO) on expression of the epidermal growth factor receptors (EGFR) HER 1 and HER 2 and consequently mucin gene expression in bronchial epithelial cells. Eosinophil accumulation and degranulation at local <b>inflammatory</b> <b>sites</b> is a feature of asthma, allergic rhinitis and nasal polyposis. Eosinophils and their granule proteins have been implicated in cell and tissue remodelling and have been shown to communicate with other cell types at <b>inflammatory</b> <b>sites,</b> including epithelial cells and nerve cells. The HER family of receptors, including HER 1 and HER 2 are activated by EGF ligands. They are upregulated in rhinosinusitis and nasal polyposis and in several human cancers. Activation of HER receptors leads to the production of mucin. We hypothesize that eosinophil cationic granule proteins including MBP and EPO will change the levels of expression and activation of the HER family and consequently of mucin genes...|$|R
40|$|Following antigen {{acquisition}} and maturation, dendritic cells (DCs) disengage from the extracellular matrix, cross basement membranes, and travel to draining lymph nodes to activate T cells. CCR 7 expression is necessary but not {{sufficient for the}} directional migration of DCs. Prostaglandin E 2 (PGE 2), present in <b>inflammatory</b> <b>sites,</b> induces DC migration, presumably by enacting a migration-permissive gene expression program. Since regulation of DC migration is highly important for their use in vaccination and therapy, we examined the PGE 2 -induced changes in the expression of metalloproteinases (MMPs). Our results indicate that PGE 2 significantly up-regulates MMP- 9 expression, induces both secreted and membrane-bound MMP- 9, and that in turn, DC-derived MMP- 9 is essential for DC chemotaxis {{in response to the}} CCR 7 ligand CCL 19, Matrigel migration, and in vivo migration in both wild-type and MMP- 9 –deficient hosts. We conclude that DCs matured within <b>inflammatory</b> <b>sites</b> require both CCR 7 and PGE 2 -induced MMP- 9 for their directional migration to draining lymph nodes...|$|R
40|$|The {{effect of}} spinal {{adenosine}} receptor ligation on peripheral leukocyte accumulation was studied in two rat models of inflammation. Neutrophil infiltration into dermal <b>inflammatory</b> <b>sites</b> was signficantly reduced by adenosine A 1 receptor agonists injected through intrathecal catheters. These effects were reversed by N-methyl-D-aspartate (NMDA), and were mimicked by (+/-) - 2 -amino- 5 -phosphonopentanoic acid (AP- 5), a glutamate NMDA receptor antagonist. Peripheral adenosine levels, as measured in air pouch exudates, decreased markedly in inflamed pouches but remained near normal after intrathecal treatment with AP- 5. Moreover, the antiinflammatory effects of intrathecal A 1 receptor agonists and AP- 5 were reversed by an adenosine A 2 receptor antagonist administered intraperitoneally. Hence, central NMDA receptor activity can regulate neutrophil accumulation in peripheral <b>inflammatory</b> <b>sites</b> by reducing local levels of adenosine, an antiinflammatory autacoid which inhibits neutrophil function through A 2 receptor activation. This represents a previously unknown pathway {{by which the}} central nervous system influences inflammatory responses...|$|R
40|$|The {{administration}} of glucocorticosteroids {{results in a}} wide range of effects on inflammatory and immunologically mediated disease processes. Glucocorticosteroids cause neutrophilic leukocytosis together with eosinopenia, monocytopenia, and lymphocytopenia. A principal mechanism whereby corticosteroids suppress inflammation is their impeding the access of neutrophils and monocytes to an <b>inflammatory</b> <b>site.</b> Granulocyte function is relatively refractory, whereas monocyte-macrophage function seems to be particularly sensitive to corticosteroids. Corticosteroid administration causes a transient lymphocytopenia of all detectable lymphocyte subpopulations, particularly the recirculating thymus-derived lymphocyte. The mechanism of this lymphocytopenia is probably a redistribution of circulating cells to other body compartments. There i...|$|E
40|$|Clinical and {{experimental}} {{evidence suggests that}} obesity-associated inflammation increases disease activity during colitis, attributed {{in part to the}} effects of Th 17 cells. Using a model of concurrent obesity and colitis, we monitored changes in critical immune cell subsets and inflammatory biomarker expression in three key tissues: visceral adipose tissue, colon (local <b>inflammatory</b> <b>site)</b> and spleen (systemic <b>inflammatory</b> <b>site),</b> and we hypothesized that n- 3 PUFA would reduce the percentage of inflammatory immune cell subsets and suppress inflammatory gene expression, thereby improving the disease phenotype. Obesity was induced in C 57 BL/ 6 mice by feeding a high fat (HF) diet (59. 2 % kcal) alone or an isocaloric HF diet supplemented with fish oil (HF-FO) for 12 weeks. Colitis was induced via a 2. 5 % trinitrobenzene sulfonic acid (TNBS) enema. The HF-FO diet improved the obese phenotype by reducing i) serum hormone concentrations (leptin and resistin), ii) adipose tissue mRNA expression of inflammatory cytokines (MCP- 1, IFNc, IL- 6, IL 17 F and IL- 21) and iii) total (F 4 / 80 + CD 11 b+) and inflammatory adipose tissue M 1 (F 4 / 80 + CD 11 c+) macrophage content compared to HF (P, 0. 05). In addition, the HF-FO diet reduced both colitis-associated disease severity and colonic mRNA expression of the Th 17 cell master transcription factor (RORct) and critical cytokines (IL- 6, IL- 17 A, IL- 17 F, IL- 21, IL- 23 and IFNc) versus HF (P, 0. 05). Compared t...|$|E
40|$|The {{aim of this}} {{research}} was to determine whether all memory T cells have the same propensity to migrate to the joint in patients with juvenile idiopathic arthritis. Paired synovial fluid and peripheral blood mononuclear cell proliferative responses to a panel of antigens were measured and the results correlated with a detailed set of laboratory and clinical data from 39 patients with juvenile idiopathic arthritis. Two distinct patterns of proliferative response were found in the majority of patients: a diverse pattern, in which synovial fluid responses were greater than peripheral blood responses for all antigens tested; and a restricted pattern, in which peripheral blood responses to some antigens were more vigorous than those in the synovial fluid compartment. The diverse pattern was generally found in patients with a high acute phase response, whereas patients without elevated acute phase proteins were more likely to demonstrate a restricted pattern. We propose that an association between the synovial fluid T cell repertoire and the acute phase response suggests that proinflammatory cytokines may influence recruitment of memory T cells to an <b>inflammatory</b> <b>site,</b> independent of their antigen specificity. Additionally, increased responses to enteric bacteria and the presence of αEβ 7 T cells in synovial fluid may reflect accumulation of gut associated T cells in the synovial compartment, {{even in the absence of}} an elevated acute phase response. This is the first report of an association between the acute phase response and the T cell population recruited to an <b>inflammatory</b> <b>site...</b>|$|E
50|$|Cathepsin G is {{a protein}} that in humans is encoded by the CTSG gene. It {{is one of}} the three serine proteases of the {{chymotrypsin}} family that are stored in the azurophil granules, and {{also a member of the}} peptidase S1 protein family, Cathepsin G plays an important role in eliminating intracellular pathogens and breaking down tissues at <b>inflammatory</b> <b>sites,</b> as well as in anti-inflammatory response.|$|R
50|$|This gene encodes {{a member}} of the beta {{chemokine}} receptor family, which is predicted to be a seven transmembrane protein similar to G protein-coupled receptors. Chemokines and their receptors are important for the migration of various cell types into the <b>inflammatory</b> <b>sites.</b> This receptor protein preferentially expresses in the thymus. The ligand of the CCR8 is CCL1. CCL8 also functions as a CCR8 agonist.|$|R
30|$|Chemokine C-C motif ligand 1 (CCL 1) accumulates C-C motif {{chemokine}} receptor 8 positive leukocytes to the <b>inflammatory</b> <b>sites.</b> Single-nucleotide polymorphisms in the chemokine CCL 1 gene {{are associated}} with exacerbation of chronic obstructive lung disease. However, {{it is unclear whether}} CCL 1 has immunomodulatory functions during pulmonary inflammation. This study aimed to elucidate this issue using newly generated transgenic mice that express CCL 1 in the lungs (SPC-CCL 1 mice).|$|R
